1 completed, 1 recruiting, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow ASC-US: new trials by email Literature Review of ASC-US trials Research Report on ASC-US
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities EGCG and Quinine Sulfate Vaginal Suppository, Placebo - High-risk HPV (Any Strain), LSIL, Low Grade Squamous Intraepithelial Lesion | Phase 2 | Recruiting | Amplexd Therapeutics, Inc. | 45 | 2026-04-30 | 2026-05-14 |
| Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL PVX-2, Placebo - ASC-US, ASC-H | Phase 2 | Terminated | PapiVax Biotech, Inc. | 16 | 2019-05-22 | 2024-06-17 |
| Probiotic Implementation as Help in Solving Vaginal Infections Lactobacillus rhamnosus BMX 54 - Vaginal Infection, ASC-US | Phase 2 | Completed | University of Roma La Sapienza | 117 | 2015-02-01 | 2017-12-13 |
Atypical Squamous Cells of the Cervix (3) · Papillomavirus Infections (2) · Candidiasis, Vulvovaginal (1) · Squamous Intraepithelial Lesions (1) · Uterine Cervical Dysplasia (1) · Vaginal Diseases (1) · Vaginitis (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Morphological and Microscopic Findings (3) · Neoplasms (3) · Pathological Conditions, Signs and Symptoms (3) · Precancerous Conditions (3) · Urogenital Diseases (3) · Uterine Cervical Diseases (3) · Uterine Diseases (3) · Communicable Diseases (2) · DNA Virus Infections (2) · Disease Attributes (2) · Infections (2)
Amplexd Therapeutics, Inc. (1) · PapiVax Biotech, Inc. (1) · University of Roma La Sapienza (1)
Hong Kong (1) · United States (1)
Kar Kei Yung, MBBS (HK), MRCOG, FHKCOG, FHKA (1) · Mark Einstein, MD, MS (1)